FDA Inspection 1039561 — Oxygen Development, L.L.C.

Oxygen Development, L.L.C. — FEI 3009461317

The FDA completed an inspection of Oxygen Development, L.L.C. on Jan 17, 2018 in Palm Springs, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 17, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Palm Springs, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.